NRGene Assembles Genome of Upland Cotton, Most Common Clothing Cotton, in less than Seven Weeks Ness Ziona, Israel – NRGene, the worldwide leader in genomic assembly and analysis, and Genosys Inc. (TGS Singapore), a leading distributor of genomics technologies in China, partnered to deliver two complete cotton genomes. “We first sequenced upland cotton (Gossypium hirsutum) in […]
Under novel collaboration approach, Schrödinger will autonomously lead discovery efforts; Takeda provides complementary structural biology support and has option to lead development and commercialization of licensed programs Osaka, Japan ＆ New York, NY – Takeda Pharmaceutical Company Limited (TSE: 4502) and Schrödinger Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, […]
Precision ID GlobalFiler NGS STR Panel v2 and Converge 2.0 software enable retrieval of more data from mixed and degraded samples CARLSBAD, Calif. — Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes, now have access to a new next-generation sequencing (NGS) STR panel from […]
Life-sciences ecosystem cuts storage costs by 50 percent, reduces complexity and drastically speeds data analysis of DNA sequencing and interpretation SAN MATEO, CA — Cloudian, Inc., a global leader in enterprise object storage systems, today announced it is working with ScaleMatrix and OnRamp BioInformatics to improve efficiencies of data analysis and storage for life sciences […]
Merck takes advantage of latest Genedata Biologics functionalities to streamline the design, production, and testing of bispecific antibodies across their therapeutic R&D programs Basel, Switzerland – Genedata, a leading provider of advanced software solutions for R&D, today announced that Merck, a leading science and technology company, has implemented Genedata Biologics™ to scale-up their bispecific antibody […]
Professor Dressman’s appointment enhances Certara’s biopharmaceutics and bioequivalence expertise PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that Professor Jennifer B. Dressman, PhD, has been appointed to the Simcyp® Scientific Advisory Board (SAB) to further strengthen its status in the biopharmaceutics field. An expert in biopharmaceutics and a […]
Today we are happy to announce that we have secured USD 5m funding from new and existing investors in an extended series C round. New funds will be used to extend Biognosys commercial operations and to accelerate the development of next generation proteomics workflows and products for high-content and high-throughput protein analysis. “The feedback that […]
Genomic analysis company Genoox has raised $6 million in funding. Inimiti Capital Partners and Glilot Capital Partners led the round. PRESS RELEASE NEW YORK – Today, Genoox, the genomic analysis company on a mission to make it easier and more affordable for doctors, clinicians and researchers to improve patient outcomes using big data, announced a […]
New York – Arsenal Capital Partners (“Arsenal”) today announced that it has agreed to sell its portfolio company, Certara (the “Company”), the leading provider of technology-driven decision support solutions for drug development, to EQT VII Fund for an enterprise value of $850 million. As part of the transaction, Arsenal Capital Partners will retain a minority ownership […]
EQT VII acquires Certara, the global leader in model-informed (in silico) drug development and regulatory science, focused on optimizing drug development and improving health outcomes Certara’s solutions help to inform and accelerate drug development and regulatory approval processes, while addressing the key efficacy, safety, productivity and commercial challenges facing the biopharma industry EQT VII to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
